EichorEICHOR
Location: Las Vegas Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Las Vegas

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · DaVita Clinical Research · R1 Therapeutics · NCT06712654
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Comprehensive Cancer Centers of Nevada · Eli Lilly and Company · NCT07218380
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Optum Care Cancer Center ( Site 9535) · Merck Sharp & Dohme LLC · NCT06393374
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · OptumCare Cancer Care at Charleston · National Cancer Institute (NCI) · NCT05564390
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 8848 · Galderma R&D · NCT06988605
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · National Cancer Institute (NCI) · NCT06172296
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · IMA Clinical Research - Las Vegas · Kallyope Inc. · NCT07674654
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
NA · Citruslabs · Zenchi, Inc. · NCT07078682
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Can
Phase 2 · Women's Cancer Center of Nevada · Aadi Bioscience, Inc. · NCT05997017
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · CC Lou Ruvo Center for Brain Health · Ad scientiam · NCT05566769
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0144 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Alliance for Childhood Diseases dba Cure 4 The Kids Foundati · PedAL BCU, LLC · NCT05183035
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · Children's Oncology Group · NCT06368817
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · National Cancer Institute (NCI) · NCT05691478
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Excel Clinical Research · Amgen · NCT07037433
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Vector Clinical Trials · Eli Lilly and Company · NCT07483099
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Digestive Disease Specialists - Las Vegas - Crimson Canyon D · Eli Lilly and Company · NCT07415044
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Pacific West Urology · Olympus Corporation of the Americas · NCT04757116
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Women's Cancer Center of Nevada ( Site 6011) · Merck Sharp & Dohme LLC · NCT07216703
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With
Phase 2 · Comprehensive Cancer Centers of Nevada · Biostar Pharma, Inc. · NCT06764940
Vascular Function in Adults With Down Syndrome
Phase N/A · University of Nevada Las Vegas - UNLV · University of Nevada, Las Vegas · NCT07630207
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Palm Research Center Tenaya · Eli Lilly and Company · NCT07369011
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · University Medical Center of Southern Nevada · Children's Oncology Group · NCT04322318
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract
Phase 3 · M3 Wake Research - Las Vegas Wellness Way · Neuvosyn Laboratories, LLC · NCT07747103
Renal Pelvic Denervation Pilot Trial
NA · DaVita Clinical Research · Verve Medical, Inc · NCT07005050
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Phase 4 · University of Nevada Las Vegas · Aurinia Pharmaceuticals Inc. · NCT07611214
Shoulder Innovations Clinical Data Registry
Phase N/A · University Medical Center of Southern Nevada · Shoulder Innovations · NCT06754150
Look up another city
Look up another condition